[Measures for prevention and therapy of cardiovascular disorders in the intra- and post-anesthetic phase].
D000769:Anesthesia, Inhalation / Q000009:adverse effects; D000777:Anesthetics / Q000009:adverse effects*; D000779:Anesthetics, Local / Q000009:adverse effects; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001810:Blood Volume / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000517:prevention & control; D003326:Coronary Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000139:chemically induced; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007022:Hypotension / Q000139:chemically induced; D009200:Myocardial Contraction / Q000187:drug effects; D010952:Plasma Substitutes / Q000009:adverse effects; D013566:Sympathomimetics / Q000009:adverse effects
D000777:Anesthetics; D000779:Anesthetics, Local; D010952:Plasma Substitutes; D013566:Sympathomimetics
Massnahmen zur Prophylaxe und Therapie kardiozirkulatorischer Störungen in der intra- und postnarkotischen Phase